Structure end function of the serine-protease subcomponents of C1: Protein engineering studies

Immunobiology

Volumn 199, Issue 2, 1998, Pages 317-326

  Gál, Péter ^a   Závodszky, Péter ^a  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; COMPLEMENT COMPONENT C1; COMPLEMENT COMPONENT C1R; COMPLEMENT COMPONENT C1S; DNA FRAGMENT; ENZYME PRECURSOR; EPIDERMAL GROWTH FACTOR RECEPTOR; LYSINE; RECOMBINANT DNA; REGULATOR PROTEIN; SERINE PROTEINASE; TETRAMER; CALCIUM; HYBRID PROTEIN;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BACULOVIRUS; CHIMERA; DELETION MUTANT; ENZYME ACTIVE SITE; GENE ACTIVATION; GENE CONTROL; GENETIC ENGINEERING; HEMOLYSIS; HUMAN; INSECT; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; AMINO ACID SUBSTITUTION; ANIMAL; BINDING SITE; CATALYSIS; CHEMICAL STRUCTURE; CHEMISTRY; CYTOLOGY; ENZYME ACTIVATION; ENZYME SPECIFICITY; GENE DELETION; GENE VECTOR; GENETICS; METABOLISM; MOTH; PHYSIOLOGY; POINT MUTATION; POLYHEDROSIS VIRUS; PROTEIN CONFORMATION; PROTEIN ENGINEERING; REVIEW; SITE DIRECTED MUTAGENESIS;

AMINO ACID SUBSTITUTION; ANIMALS; BINDING SITES; CALCIUM; CATALYSIS; COMPLEMENT C1R; COMPLEMENT C1S; ENZYME ACTIVATION; ENZYME PRECURSORS; GENETIC VECTORS; HUMANS; MODELS, MOLECULAR; MOTHS; MUTAGENESIS, SITE-DIRECTED; NUCLEOPOLYHEDROVIRUS; POINT MUTATION; PROTEIN CONFORMATION; PROTEIN ENGINEERING; RECOMBINANT FUSION PROTEINS; SEQUENCE DELETION; SUBSTRATE SPECIFICITY;

EID: 0031593752     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0171-2985(98)80036-3     Document Type: Article

References (31)

1. ARLAUD, G. J., M. G. COLOMB, and J. GAGNON. 1987. A functional model of the human C1 complex. Immun. Today 8: 106.
2. SCHUMAKER, V. N., P. ZÁVODSZKY, and P. H. POON. 1987. Activation of the first component of complement. A. Rev. Immunol. 5: 21.
3. JIANG, H., D. BURDICK, C. G. GLABE, C. W. COTMAN, and A. J. TENNER. 1994. β-amyloid activates complement by binding to a specific region of the collagen-like domain of the C1q A chain. J. Immunol. 152: 5050.
4. WEISS, V., C. FAUSER, and J. ENGEL. 1986. Functional model of subcomponent C1 of human complement. J. Mol. Biol. 189: 573.
5. COLOMB, M. G., G. J. ARLAUD, and C. L. VILLIERS. 1984. Activation of C1. Philos. Trans. R. Soc. London B 306: 283.
6. COOPER, N. R. 1985. The classical complement pathway: activation and regulation of the first complement component. Adv. Immunol. 37: 151.
7. REID, K. B. M., R. B. SIM, and A. P. FAIERS. 1977. Inhibition of the reconstitution of the hemolytic activity of the first component of human complement by a pepsine-derived fragment of subcomponent C1q. Biochem. J. 161: 239.
8. ARLAUD, G. J., and J. GAGNON. 1985. Identification of the peptide bond cleaved during activation of human C1r. FEBS Lett. 180: 234.
9. SPYCHER, S. E., H. NICK, and E. E. RICKLI. 1986. Human complement component C1s. Partial sequence determination of the heavy chain and identification of the peptide bond cleaved during activation. Eur. J. Biochem. 156: 49.
10. LEYTUS, S. P., K. KURACHI, K. S. SAKARIASSEN, and E. W. DAVIE. 1986. Nucleotide sequence of the cDNA coding for human complement C1r. Biochemistry 25: 4855.
11. TOSI, M., C. DUPOUNCHEL, T. MEO, and C. JULIER. 1987. Complete cDNA sequence of human complement C1s and close physical linkage of the homologous genes C1s and C1r. Biochemistry 26: 8516.
12. MACKINNON, C. M., P. E. CARTER, S. J. SMITH, B. DUNBAR, and J. E. FOTHERGILL. 1987. Molecular cloning of cDNA for human complement component C1s. The complete amino acid sequence. Eur. J. Biochem. 169: 547.
13. GÁL, P., M. SÁRVÁRI, K. SZILÁGYI, P. ZÁVODSZKY, and V. N. SCHUMAKER. 1989. Expression of hemolytically active human complement component C1r proenzyme in insect cells using a baculovirus vector. Complement and Inflammation 6: 433.
14. LUO, C., N. M. THIELENS, J. GAGNON, P. GÁL, M. SÁRVÁRI, Y. TSENG, M. TOSI, P. ZÁVODSZKY, G. J. ARLAUD, and V. N. SCHUMAKER. 1992. Recombinant human complement subcomponent C1s lacking β-hydroxyasparagine, sialic acid, and one of its two carbohydrate chains still reassembles with C1q and C1r to form a functional C1 complex. Biochemistry 31: 4254.
15. SÁRVÁRI, M., GY. CSIKÓS, M. SASS, P. GÁL, V. N. SCHUMAKER, and P. ZÁVODSZKY. 1990. Ecdysteroids increase the yield of recombinant protein produced in baculovirus insect cell expression system. Biochem. Biophys. Res. Commun. 167: 1154.
16. O'REILLY, D. R., L. K. MILLER, and V. A. LUCKOW. 1992. Baculovirus expression vectors. Freeman V. H. and Company, New York.
17. RAPP, H. J., and T. BORSOS. 1970. Molecular basis of complement action. Appleton-Century-Corfts, New York.
18. TSCHOPP, J., W. VILLIGER, H. FUCHS, E. KILCHHERR, and J. ENGEL. 1980. Assembly of subcomponents C1r and C1s of first component of complement: electron microscope and ultracentrifugal studies. Proc. Natl. Acad. Sci. USA 77: 7014.
19. VILLIERS, C. L., G. J. ARLAUD, and M. G. COLOMB. 1985. Domain structure and associated functions of subcomponents C1r and C1s of the first component of human complement. Proc. Natl. Acad. Sci. USA 82: 4477.
20. ARLAUD, G. J., C. L. VILLIERS, S. SHESNE, and M. G. COLOMB. 1980. Purified proenzyme C1r some characteristics of activation and subsequent proteolytic cleavage. Biochim. Biophys. Acta 616: 116.
21. 2-terminal calcium-binding domain of human complement C1s mediates the interaction of C1r with C1q. Biochemistry 29: 4613.
22. 2-terminal α fragment of human complement proteases C1r and C1s. J. Biol. Chem. 265: 14469.
23. MONKOVICH, D. D., W. J. VANDUSEN, C. J. PETROSKI, V. M. GARSKY, M. K. SARDANA, P. ZÁVODSZKY, A. M. STERN, and P. A. FRIEDMAN. 1992. Invertebrate aspartyl/asparaginyl β-hydroxylase: Potential modification of endogeneous epidermal growth factor-like modules. Biochem. Biophys. Res. Commun. 189: 233.
24. CSEH, S., P. GÁL, M. SÁRVÁRI, J. DOBÓ, Zs. LÖRINCZ, V. N. SCHUMAKER, and P. ZÁVODSZKY. 1996. Functional effects of domain deletions in a multidomain serine protease, C1r. Mol. Immunol. 33: 351.
25. ZICCARDI, R. J., and N. R. COOPER. 1976. Physiochemical and functional characterization of the C1r subunit of the first complement component. J. Immunol. 116: 496.
26. VILLIERS, C. L., A.-N. DUPLAA, G. J. ARLAUD, and M. G. COLOMB. 1982. Fluid phase activation of proenzymic C1r purified by affinity chromatography. Biochim. Biophys. Acta 700: 118.
27. LACROIX, M. B., C. A. AUDE, G. J. ARLAUD, and M. G. COLOMB. 1989. Isolation and functional characterization of the proenzyme form of the catalytic domains of human C1r. Biochem. J. 257: 885.
28. DOBÓ, J., P. GÁL, K. SZILÁGYI, S. CSEH, Zs. LÖRINCZ, V. N. SCHUMAKER, and P. ZÁVODSZKY. 1997. A single active C1r is sufficient for the activity of the complement C1 complex. Stabilization of C1r in the zymogen form by point mutations. (submitted for publication).
29. DODDS, A. W., R. B. SIM, R. R. PORTER, and M. A. KERR. 1978. Activation of the first component of human complement (C1) by antibody-antigen aggregates. Biochem. J. 175: 383.
30. KASAHARA, Y., K. TAKAHASHI, S. NAGASAWA, and J. KAYAMA. 1982. Formation of a conformationally changed C1r, a subcomponent of the first component of human complement, as an intermediate of its autoactivation reaction. FEBS Lett. 141: 128.
31. PATTHY, L. 1985. Evolution of the proteases of blood coagulation and fibrinolysis by assembly from modules. Cell 41: 657.